
What happened
The Blue Cross Blue Shield Association's analysis found that hospitals' use of AI tools in insurance claims led to an additional $942 million in healthcare spending over a two-year period, citing a sharp increase in patients documented as having complex conditions.
Why it matters
The analysis points to a disconnect between medical coding and treatment, since there is no evidence of a corresponding change in care delivered, which insurers say shifts costs onto them.
What to watch
The BCBSA's Luke Chalker called the situation a completely one-sided blood bath with insurers on the losing side, while Abridge founder Dr. Shiv Rao said AI might instead reduce tensions and cut costs.
WHO IT HITSHealth insurers and hospital billing teams face a coding and payment dispute driven by AI-assisted claims. Employers and plan sponsors funding coverage may also see cost pressure if the spending increase persists.
Summaries like this, every morning.
Hospitals and insurers have long clashed over treatments and payments, but the New York Times pointed to the BCBSA analysis as the latest sign that AI on both sides is making things worse. The insurer group's data focuses on a documentation shift during claims submission: more patients recorded as having complex conditions, without what it calls evidence of a corresponding change in care delivered.
The disagreement over how to frame this is itself notable. Luke Chalker, a BCBSA senior vice president, rejected the language of a battle and described a completely one-sided blood bath with insurers losing. Dr. Shiv Rao of the AI startup Abridge offered the opposite possibility, warning of a horrible dystopic future where bots and agents fight each other, but also suggesting AI might reduce tensions and cut costs.
What happens next may hinge on whether payers can show that coding changes are untethered from actual treatment, or whether hospitals can demonstrate that AI is surfacing conditions that were previously missed. For insurers and the employers who fund coverage, the stakes are whether that $942 million figure reflects a one-time adjustment or an ongoing pattern, while for hospitals and clinicians the question is whether AI tools are treated as a billing problem or a care improvement.
Pick your industry and the AI tools you use, and get news related to your work every day.
Free · 30 seconds with Google · unsubscribe anytimeWhat is AIToday? →
Ask AI anything about this article. The AI reads this article, earlier AIToday articles, and Wikipedia, and cites its sources. Q&As are published on this page for other readers too.
Elon Musk said SpaceX is bringing on about half a gigawatt per month of AI compute — roughly 220,000 Nvidia GB…

UiPath trades at 14.3x forward earnings and 3.4x sales, below the S&P 500's roughly 19x, while Palantir trades…

Remedy Robotics raised $62 million in Series B funding led by DCVC, with UC Investments, Skip Capital and Host…

Genesis AI raised $500 million in Series A funding at a post-money valuation of $3.5 billion, with Premji Inve…

ShowGo began handing CEO work to Claude Code in late October; October take-home was ¥0, and the two paid apps…

Anthropic's S-1, reported by Reuters to carry about 80 pages of risk factors, lists AI risks beyond losses and…
